Business Standard

Market approval for Covishield, Covaxin likely to come with riders

Will the vaccines be freely available with chemists?

vaccination
Premium

Who will decide who gets the vaccine?

Ruchika Chitravanshi New Delhi
The subject expert committee’s recommendation for regular market approval to Covishield and Covaxin, if accepted by the regulator, could be subject to some conditions, the government has indicated. 

There is lack of clarity at present on whether the market authorisation for the vaccines means these would be available at chemist shops for the general public to buy and if the vaccine makers would be allowed to sell them freely. 

Health Secretary Rajesh Bhushan said, “Whether the approval would be with certain conditions will be known in the future. Once that decision is taken, these questions will be answered.” 

Experts said, in principle, such

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in